278 related articles for article (PubMed ID: 21911720)
1. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
5. Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study.
Buijs C; Mom CH; Willemse PH; Marike Boezen H; Maurer JM; Wymenga AN; de Jong RS; Nieboer P; de Vries EG; Mourits MJ
Breast Cancer Res Treat; 2009 Jun; 115(3):573-80. PubMed ID: 18670875
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
Taleghani SY; Etesam F; Esfandbod M
Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
[TBL] [Abstract][Full Text] [Related]
8. Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study.
Pandya KJ; Raubertas RF; Flynn PJ; Hynes HE; Rosenbluth RJ; Kirshner JJ; Pierce HI; Dragalin V; Morrow GR
Ann Intern Med; 2000 May; 132(10):788-93. PubMed ID: 10819701
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
[TBL] [Abstract][Full Text] [Related]
11. Comparison of citalopram and venlafaxine's role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial.
Davari-Tanha F; Soleymani-Farsani M; Asadi M; Shariat M; Shirazi M; Hadizadeh H
Arch Gynecol Obstet; 2016 May; 293(5):1007-13. PubMed ID: 26437957
[TBL] [Abstract][Full Text] [Related]
12. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
14. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
[TBL] [Abstract][Full Text] [Related]
15. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
[TBL] [Abstract][Full Text] [Related]
17. Nonestrogenic management of hot flashes.
Loprinzi CL; Barton DL; Qin R
J Clin Oncol; 2011 Oct; 29(29):3842-6. PubMed ID: 21911722
[No Abstract] [Full Text] [Related]
18. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study.
Barton D; La Vasseur B; Loprinzi C; Novotny P; Wilwerding MB; Sloan J
Oncol Nurs Forum; 2002; 29(1):33-40. PubMed ID: 11817491
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Irani J; Salomon L; Oba R; Bouchard P; Mottet N
Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
